HUE038700T2 - Benzofuran-2-szulfonamid származékok, mint kemokinreceptor-modulációk - Google Patents
Benzofuran-2-szulfonamid származékok, mint kemokinreceptor-modulációkInfo
- Publication number
- HUE038700T2 HUE038700T2 HUE13711995A HUE13711995A HUE038700T2 HU E038700 T2 HUE038700 T2 HU E038700T2 HU E13711995 A HUE13711995 A HU E13711995A HU E13711995 A HUE13711995 A HU E13711995A HU E038700 T2 HUE038700 T2 HU E038700T2
- Authority
- HU
- Hungary
- Prior art keywords
- benzofuran
- chemokine receptor
- receptor modulators
- sulfonamide derivatives
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605300P | 2012-03-01 | 2012-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE038700T2 true HUE038700T2 (hu) | 2018-11-28 |
Family
ID=47902352
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18156011A HUE049728T2 (hu) | 2012-03-01 | 2013-03-01 | Benzofurán-2-szulfonamid származékok, mint kemokin receptor modulátorok |
| HUE13711995A HUE038700T2 (hu) | 2012-03-01 | 2013-03-01 | Benzofuran-2-szulfonamid származékok, mint kemokinreceptor-modulációk |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18156011A HUE049728T2 (hu) | 2012-03-01 | 2013-03-01 | Benzofurán-2-szulfonamid származékok, mint kemokin receptor modulátorok |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8815915B2 (hu) |
| EP (2) | EP2820010B1 (hu) |
| AU (2) | AU2013225815B2 (hu) |
| CA (1) | CA2866078C (hu) |
| CY (1) | CY1120528T1 (hu) |
| DK (2) | DK2820010T3 (hu) |
| ES (2) | ES2791534T3 (hu) |
| HU (2) | HUE049728T2 (hu) |
| PL (2) | PL2820010T3 (hu) |
| PT (2) | PT3345899T (hu) |
| SI (1) | SI2820010T1 (hu) |
| WO (2) | WO2013130958A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE049728T2 (hu) | 2012-03-01 | 2020-10-28 | Allergan Inc | Benzofurán-2-szulfonamid származékok, mint kemokin receptor modulátorok |
| ES2708563T3 (es) * | 2013-03-12 | 2019-04-10 | Allergan Inc | Derivados de sulfonamida como moduladores de receptores de quimiocinas |
| AR098583A1 (es) * | 2013-12-02 | 2016-06-01 | Allergan Inc | Compuesto de sulfonamida de benzotiofeno, composición farmacéutica que lo comprende y su uso para la preparación de dicha composición |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003099773A1 (en) | 2002-05-24 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
| WO2005004810A2 (en) | 2003-07-02 | 2005-01-20 | Merck & Co., Inc. | Arylsulfonamide derivatives |
| PT1651621E (pt) * | 2003-08-08 | 2008-09-30 | Janssen Pharmaceutica Nv | Compostos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de cck2 |
| US7622583B2 (en) * | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
| US7931909B2 (en) | 2005-05-10 | 2011-04-26 | Allergan, Inc. | Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates |
| GB0524786D0 (en) * | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
| NZ574759A (en) | 2006-07-14 | 2010-10-29 | Chemocentryx Inc | Triazolyl phenyl benzenesulfonamides |
| WO2008008374A2 (en) | 2006-07-14 | 2008-01-17 | Chemocentryx, Inc. | Ccr2 inhibitors and methods of use thereof |
| US8519135B2 (en) | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
| EP2175859B1 (en) | 2007-07-12 | 2012-03-07 | ChemoCentryx, Inc. | Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
| TWI440638B (zh) | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
| CN108383828A (zh) * | 2010-12-16 | 2018-08-10 | 阿勒根公司 | 作为趋化因子受体调节剂的新的1，2-双-磺酰胺衍生物 |
| BR112013015234B1 (pt) * | 2010-12-16 | 2020-04-22 | Allergan Inc | composto e composição farmacêutica |
| CA2859024C (en) * | 2011-12-12 | 2016-11-08 | Allergan, Inc. | Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators |
| HUE049728T2 (hu) * | 2012-03-01 | 2020-10-28 | Allergan Inc | Benzofurán-2-szulfonamid származékok, mint kemokin receptor modulátorok |
| ES2708563T3 (es) * | 2013-03-12 | 2019-04-10 | Allergan Inc | Derivados de sulfonamida como moduladores de receptores de quimiocinas |
-
2013
- 2013-03-01 HU HUE18156011A patent/HUE049728T2/hu unknown
- 2013-03-01 US US13/782,174 patent/US8815915B2/en active Active
- 2013-03-01 EP EP13711995.4A patent/EP2820010B1/en active Active
- 2013-03-01 SI SI201331119T patent/SI2820010T1/sl unknown
- 2013-03-01 DK DK13711995.4T patent/DK2820010T3/en active
- 2013-03-01 ES ES18156011T patent/ES2791534T3/es active Active
- 2013-03-01 ES ES13711995.4T patent/ES2683046T3/es active Active
- 2013-03-01 WO PCT/US2013/028599 patent/WO2013130958A1/en active Application Filing
- 2013-03-01 PL PL13711995T patent/PL2820010T3/pl unknown
- 2013-03-01 CA CA2866078A patent/CA2866078C/en active Active
- 2013-03-01 EP EP18156011.1A patent/EP3345899B1/en active Active
- 2013-03-01 HU HUE13711995A patent/HUE038700T2/hu unknown
- 2013-03-01 WO PCT/US2013/028607 patent/WO2013130962A1/en active Application Filing
- 2013-03-01 PL PL18156011T patent/PL3345899T3/pl unknown
- 2013-03-01 PT PT181560111T patent/PT3345899T/pt unknown
- 2013-03-01 DK DK18156011.1T patent/DK3345899T3/da active
- 2013-03-01 US US13/782,159 patent/US8927544B2/en active Active
- 2013-03-01 PT PT13711995T patent/PT2820010T/pt unknown
- 2013-03-01 AU AU2013225815A patent/AU2013225815B2/en active Active
-
2014
- 2014-07-17 US US14/334,145 patent/US9416120B2/en active Active
-
2015
- 2015-01-05 US US14/589,681 patent/US9550746B2/en active Active
-
2018
- 2018-01-11 AU AU2018200226A patent/AU2018200226B2/en active Active
- 2018-08-07 CY CY20181100816T patent/CY1120528T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8927544B2 (en) | 2015-01-06 |
| WO2013130962A1 (en) | 2013-09-06 |
| WO2013130958A1 (en) | 2013-09-06 |
| US9416120B2 (en) | 2016-08-16 |
| DK2820010T3 (en) | 2018-08-06 |
| EP2820010A1 (en) | 2015-01-07 |
| SI2820010T1 (sl) | 2018-11-30 |
| AU2018200226A1 (en) | 2018-01-25 |
| CA2866078C (en) | 2018-01-02 |
| CY1120528T1 (el) | 2019-07-10 |
| DK3345899T3 (da) | 2020-05-11 |
| US8815915B2 (en) | 2014-08-26 |
| PT3345899T (pt) | 2020-05-20 |
| US20130231339A1 (en) | 2013-09-05 |
| CA2866078A1 (en) | 2013-09-06 |
| US9550746B2 (en) | 2017-01-24 |
| EP3345899B1 (en) | 2020-02-19 |
| US20140329813A1 (en) | 2014-11-06 |
| US20150218119A1 (en) | 2015-08-06 |
| PL2820010T3 (pl) | 2018-11-30 |
| PL3345899T3 (pl) | 2020-07-27 |
| US20130231338A1 (en) | 2013-09-05 |
| EP2820010B1 (en) | 2018-05-09 |
| HUE049728T2 (hu) | 2020-10-28 |
| AU2013225815B2 (en) | 2017-10-12 |
| EP3345899A1 (en) | 2018-07-11 |
| PT2820010T (pt) | 2018-10-01 |
| AU2013225815A1 (en) | 2014-09-25 |
| ES2791534T3 (es) | 2020-11-04 |
| AU2018200226B2 (en) | 2019-09-19 |
| ES2683046T3 (es) | 2018-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1232219A1 (zh) | 作為趨化因子受體調節劑的硫衍生物 | |
| IL237212A0 (en) | Amide derivatives of benzoimidazole carboxylic acid as apj receptor modulators | |
| GB201213700D0 (en) | Receptor antagnists II | |
| IL251897A0 (en) | X-receptor modulators of the liver | |
| HK1206333A1 (en) | Liver receptor modulators | |
| HK1208867A1 (en) | Indolecarbonitriles as selective androgen receptor modulators | |
| HK1209744A1 (en) | Novel selective androgen receptor modulators | |
| HK1211025A1 (en) | Indolines | |
| IL235557B (en) | Modulators of 17 gpr receptors | |
| GB201217285D0 (en) | Indole derivatives | |
| HUE049728T2 (hu) | Benzofurán-2-szulfonamid származékok, mint kemokin receptor modulátorok | |
| GB201223053D0 (en) | Receptor | |
| AU2012904244A0 (en) | Neurotrophin-tyrosine kinase receptor signaling |